DF

David R. Fogelman

Merck & Co., Inc., Rahway, NJ, USA (United States) US

ORCID iD 0000-0002-4063-189X
232
Publications
6,898
Citations
46
H-Index
92
i10-Index
1.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

Pancreatic and Hepatic Oncology Research (92) Colorectal Cancer Treatments and Studies (86) Cancer Genomics and Diagnostics (78) Genetic factors in colorectal cancer (32) Neuroendocrine Tumor Research Advances (26)

Affiliations

Novartis (Switzerland)
CH 2019 - 2019
Merck & Co., Inc., Rahway, NJ, USA (United States)
US 2026 - 2021
Morgan Stanley Children's Hospital
US 2006 - 2006
Montefiore Medical Center
US 2006 - 2005
The University of Texas MD Anderson Cancer Center
US 2022 - 2008

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now